Literature DB >> 28137893

STAT3 Activation Impairs the Stability of Th9 Cells.

Benjamin J Ulrich1,2, Felipe Fortino Verdan3, Andrew N J McKenzie4, Mark H Kaplan5,2, Matthew R Olson5.   

Abstract

Th9 cells regulate multiple immune responses, including immunity to pathogens and tumors, allergic inflammation, and autoimmunity. Despite ongoing research into Th9 development and function, little is known about the stability of the Th9 phenotype. In this study, we demonstrate that IL-9 production is progressively lost in Th9 cultures during several rounds of differentiation. The loss of IL-9 is not due to an outgrowth of cells that do not secrete IL-9, as purified IL-9 secretors demonstrate the same loss of IL-9 in subsequent rounds of differentiation. The loss of IL-9 production correlates with increases in phospho-STAT3 levels within the cell, as well as the production of IL-10. STAT3-deficient Th9 cells have increased IL-9 production that is maintained for longer in culture than IL-9 in control cultures. IL-10 is responsible for STAT3 activation during the first round of differentiation, and it contributes to instability in subsequent rounds of culture. Taken together, our results indicate that environmental cues dictate the instability of the Th9 phenotype, and they suggest approaches to enhance Th9 activity in beneficial immune responses.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28137893      PMCID: PMC5340611          DOI: 10.4049/jimmunol.1601624

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Cutting edge: an IL-17F-CreEYFP reporter mouse allows fate mapping of Th17 cells.

Authors:  Andrew L Croxford; Florian C Kurschus; Ari Waisman
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

2.  Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions.

Authors:  Ahmed N Hegazy; Michael Peine; Caroline Helmstetter; Isabel Panse; Anja Fröhlich; Andreas Bergthaler; Lukas Flatz; Daniel D Pinschewer; Andreas Radbruch; Max Löhning
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

3.  TH9 cells are required for tissue mast cell accumulation during allergic inflammation.

Authors:  Sarita Sehra; Weiguo Yao; Evelyn T Nguyen; Nicole L Glosson-Byers; Nahid Akhtar; Baohua Zhou; Mark H Kaplan
Journal:  J Allergy Clin Immunol       Date:  2015-03-05       Impact factor: 10.793

4.  IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma.

Authors:  E Schmitt; T Germann; S Goedert; P Hoehn; C Huels; S Koelsch; R Kühn; W Müller; N Palm; E Rüde
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

5.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

6.  Th17 cells demonstrate stable cytokine production in a proallergic environment.

Authors:  Nicole L Glosson-Byers; Sarita Sehra; Gretta L Stritesky; Qing Yu; Olufolakemi Awe; Duy Pham; Heather A Bruns; Mark H Kaplan
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

7.  IL-23 promotes maintenance but not commitment to the Th17 lineage.

Authors:  Gretta L Stritesky; Norman Yeh; Mark H Kaplan
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.

Authors:  Frédérique Végran; Hélène Berger; Romain Boidot; Grégoire Mignot; Mélanie Bruchard; Magalie Dosset; Fanny Chalmin; Cédric Rébé; Valentin Dérangère; Bernhard Ryffel; Masashi Kato; Armelle Prévost-Blondel; François Ghiringhelli; Lionel Apetoh
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

9.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

10.  Fate mapping of IL-17-producing T cells in inflammatory responses.

Authors:  Keiji Hirota; João H Duarte; Marc Veldhoen; Eve Hornsby; Ying Li; Daniel J Cua; Helena Ahlfors; Christoph Wilhelm; Mauro Tolaini; Ursula Menzel; Anna Garefalaki; Alexandre J Potocnik; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

View more
  10 in total

1.  Calcitriol Regulates the Differentiation of IL-9-Secreting Th9 Cells by Modulating the Transcription Factor PU.1.

Authors:  Shachi Pranjal Vyas; Arman Kunwar Hansda; Mark H Kaplan; Ritobrata Goswami
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

2.  BATF-Interacting Proteins Dictate Specificity in Th Subset Activity.

Authors:  Yongyao Fu; Byunghee Koh; Makoto Kuwahara; Benjamin J Ulrich; Rakshin Kharwadkar; Masakatsu Yamashita; Mark H Kaplan
Journal:  J Immunol       Date:  2019-08-26       Impact factor: 5.422

3.  Expression Efficiency of Multiple Il9 Reporter Alleles Is Determined by Cell Lineage.

Authors:  Rakshin Kharwadkar; Benjamin J Ulrich; Amina Abdul Qayum; Byunghee Koh; Paula Licona-Limón; Richard A Flavell; Mark H Kaplan
Journal:  Immunohorizons       Date:  2020-05-21

Review 4.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

Review 5.  The γ c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response.

Authors:  Rosanne Spolski; Daniel Gromer; Warren J Leonard
Journal:  F1000Res       Date:  2017-10-23

Review 6.  STAT3, a Master Regulator of Anti-Tumor Immune Response.

Authors:  Cédric Rébé; François Ghiringhelli
Journal:  Cancers (Basel)       Date:  2019-08-30       Impact factor: 6.639

7.  Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions.

Authors:  Yingying Shen; Zhengbo Song; Xinliang Lu; Zeyu Ma; Chaojie Lu; Bei Zhang; Yinghu Chen; Meng Duan; Lionel Apetoh; Xu Li; Jufeng Guo; Ying Miao; Gensheng Zhang; Diya Yang; Zhijian Cai; Jianli Wang
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

8.  STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation.

Authors:  D Alejandro Canaria; Bingyu Yan; Maia G Clare; Zonghao Zhang; Grace A Taylor; David L Boone; Majid Kazemian; Matthew R Olson
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

9.  Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation.

Authors:  Xiang Xiao; Yihui Fan; Junhui Li; Xiaolong Zhang; Xiaohua Lou; Yaling Dou; Xiaomin Shi; Peixiang Lan; Yue Xiao; Laurie Minze; Xian Chang Li
Journal:  J Exp Med       Date:  2018-01-16       Impact factor: 14.307

Review 10.  Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction.

Authors:  Sakshi Malik; Amit Awasthi
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.